Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATHENA: Dronedarone in AF/AFL
NCT00174785Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 37
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) and atrial flutter (AFL) comparing Dronedarone with Placebo (2 arms). Primary endpoint: First Hospitalization for Cardiovascular Reason or Death From Any Cause. Started Jun 2005; status: completed.
02
Drugs
dronedarone
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT00174785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174785.